Implementation of a smartphone survey and mainstreaming for genetic cancer risk assessment in a diverse, urban, Medicaid-predominant gynecology clinic: a step toward health equity - 14/02/24
Doi : 10.1016/j.ajog.2024.01.009
Emily M. Webster, MD 
, Muhammad Danyal Ahsan, MD
, Muhammad Danyal Ahsan, MD Division of Gynecology Oncology, Department of Obstetrics and Gynecology, Weill Cornell Medicine, 525 East 68th Street, Suite J-130, New York, NY 10065
Melissa K. Frey, MD, MS
Division of Gynecology Oncology, Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Wednesday 14 February 2024
Le texte complet de cet article est disponible en PDF.
Plan
| E.M.W. and M.D.A. are co-first authors. |
|
| R.N.S. and M.K.F. are co-senior authors. |
|
| The authors report no conflict of interest. |
|
| M.K.F. was supported by the American Board of Obstetrics and Gynecology–American Association of Obstetricians and Gynecologists Foundation Scholar Award. R.N.S. was supported by the National Cancer Institute under grant number K07CA216326 and R01CA211723 and the Patient Centered Outcomes Research Institute under grant number IHS-2017C3-9211. The funding sources had no role in the study design; collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. |
|
| A subset of this data was presented at the Annual Meeting on Women's Cancer of the Society of Gynecologic Oncology, Tampa, FL, March 24–28, 2023; and at the International Symposium for Hereditary Breast and Ovarian Cancer, Montreal, Quebec, Canada, May 2–5, 2023. |
© 2024
Elsevier Inc. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?